A multinational, multi-tumour basket study in very rare cancer types: The European Organization for Research and Treatment of Cancer phase II 90101 'CREATE' trial

Eur J Cancer. 2019 Mar:109:192-195. doi: 10.1016/j.ejca.2018.12.013. Epub 2019 Jan 14.
No abstract available

Keywords: Basket trial; Clinical trial; Crizotinib; Methodology of clinical research; Targeted therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Clinical Trials, Phase II as Topic
  • Follow-Up Studies
  • Humans
  • International Agencies
  • Multicenter Studies as Topic
  • Neoplasms* / classification
  • Neoplasms* / drug therapy
  • Neoplasms* / pathology
  • Prognosis
  • Rare Diseases* / classification
  • Rare Diseases* / drug therapy
  • Rare Diseases* / pathology
  • Survival Rate